SCHEMBL8683591

SCHEMBL8683591

CCOC(=O)c1ccc2c(c1)C(CCCNc1ccccn1)(c1ccccc1)N=N2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.43
▸ RAB9A P51151 3/20 0.43
▸ HTT P42858 1/20 0.42
▸ MAPT P10636 2/20 0.36
▸ GAA P10253 1/20 0.36
▸ HCAR3 P49019 2/20 0.36
▸ MEN1 O00255 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ ITGB3 P05106 4/20 0.36
▸ ITGAV P06756 4/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ ITGB1 P05556 2/20 0.35
▸ ITGB5 P18084 1/20 0.35
▸ ITGB6 P18564 1/20 0.35
▸ ICMT O60725 1/20 0.35
▸ ITGA5 P08648 1/20 0.35
▸ TP53 P04637 2/20 0.35
▸ THRB P10828 2/20 0.35
▸ PTGER4 P35408 1/20 0.35
▸ JMJD6 Q6NYC1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8682249 0.84 NPC1 (0.41) NPC1RAB9AHTTMAPTGAA
SCHEMBL8683782 0.82 ICMT (0.34) NPC1RAB9AMAPTGAAMEN1
SCHEMBL8683588 0.76 NPC1 (0.44) NPC1RAB9AHTTMAPTGAA
SCHEMBL7377874 0.68 TOP2A (0.53) NPC1RAB9AHTTITGB3ITGAV
SCHEMBL11562843 0.67 HCAR3 (0.54) NPC1RAB9AMAPTGAAHCAR3
SCHEMBL8684069 0.67 RAB9A (0.46) NPC1RAB9AHTTMAPTGAA
SCHEMBL14289015 0.67 ITGB3 (0.60) NPC1RAB9AHTTMEN1KMT2A
SCHEMBL15714331 0.67 TOP2A (0.52) NPC1RAB9AITGB3ITGAVALDH1A1
SCHEMBL11954569 0.66 TOP2A (0.57) NPC1RAB9AHTTITGB3ITGAV
SCHEMBL9592348 0.66 HCAR3 (0.70) NPC1RAB9AMAPTHCAR3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5760028-A TREATING CANCER METASTASIS, DIABETIC RETINOPATHY, NEOVASCULAR GLAUCOMA, THROMBOSIS, RESTENOSIS, OSTEOPOROSIS, MACULAR DEGENERATION THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-06-02 — — US disclosed
Send feedback